Le Lézard
Classified in: Transportation, Health
Subjects: LEG, LBR, AVO

Teamsters Support Bipartisan Effort In Senate To Repeal Cadillac Tax


WASHINGTON, July 28, 2017 /PRNewswire-USNewswire/ -- Teamsters General President Jim Hoffa applauded the efforts of Sen. Dean Heller (R-NV) and Sen. Martin Heinrich (D-NM) to repeal the 40 percent excise tax on comprehensive insurance plans included in the Affordable Care Act (ACA) and commended Senators who joined the effort and voted for repeal. Though the effort was not successful, the senators that supported repeal continue to demonstrate that they will fight for affordable health care for the middle class.

International Brotherhood Of Teamsters. (PRNewsFoto/International Brotherhood of Teamsters)

Currently, the excise tax, commonly referred to as the Cadillac Tax, places a 40 percent tax on high-quality health care plans. This tax will only hurt working men and women who will see their premiums rise as costs are passed down the line.

"Senators on both sides of the aisle are doing the right thing and fighting to repeal this harmful tax on good health care plans," Hoffa said. "I thank them for standing strong and continuing to fight for their constituents who can't afford to see their health insurance costs rise."

Founded in 1903, the International Brotherhood of Teamsters represents 1.4 million hardworking men and women throughout the United States, Canada and Puerto Rico. Visit www.teamster.org for more information. Follow us on Twitter @Teamsters and "like" us on Facebook at www.facebook.com/teamsters.

Contact: 
Galen Munroe, (202) 624-6911
[email protected]

 

SOURCE International Brotherhood of Teamsters


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: